1.
Arch Dis Child
; 84(5): 432-3, 2001 May.
Article
in English
| MEDLINE
| ID: mdl-11316693
ABSTRACT
Nebulised colistin is regularly used as antipseudomonal therapy in children with cystic fibrosis. We assessed bronchoconstriction in response to nebulised colistin in 58 children. Nebulised colistin significantly reduced FEV(1), MEF(25%), and SaO(2) for 15 minutes. In 20 children the reduction was greater than 10% from baseline FEV(1), and was still at that level in five at 30 minutes. Subjective assessment, baseline FEV(1), and serum IgE were unable to identify susceptible children. It is recommended that children receiving colistin should be carefully assessed for bronchoconstriction.
Subject(s)
Anti-Bacterial Agents/adverse effects , Bronchoconstriction/drug effects , Colistin/adverse effects , Cystic Fibrosis/drug therapy , Administration, Inhalation , Adolescent , Anti-Bacterial Agents/administration & dosage , Child , Child, Preschool , Colistin/administration & dosage , Cross-Sectional Studies , Cystic Fibrosis/physiopathology , Forced Expiratory Volume/drug effects , Humans , Prospective Studies
2.
Community Nurse
; 3(6): 10-1, 1997 Jul.
Article
in English
| MEDLINE
| ID: mdl-9469042
3.
Nurs Times
; 71(44): 1752, 1975 Oct 30.
Article
in English
| MEDLINE
| ID: mdl-1196954
4.
Nurs Mirror Midwives J
; 139(9): 39-40, 1974 Aug 30.
Article
in English
| MEDLINE
| ID: mdl-4497241